New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NILE;EW;HP;NCS;NBR;NOV;OII;OIS;PTEN;PDS;SFLY;SSH;SPN;ZTS;ARP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
August 3, 2015
08:49 EDTHPHelmerich & Payne upgraded to Accumulate from Neutral at Global Hunter
Subscribe for More Information
08:00 EDTSPNSuperior Energy risk/reward compelling, says Oppenheimer
Subscribe for More Information
July 31, 2015
10:02 EDTNOV, ARPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:59 EDTARPAtlas Resource Partners downgraded to Hold from Buy at Stifel
Subscribe for More Information
07:10 EDTNOVNational Oilwell downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
July 30, 2015
17:14 EDTSPNSuperior Energy sees general and administrative costs 10%-15% below 2014 levels
Subscribe for More Information
17:12 EDTSPNSuperior Energy reports Q2 adjusted EPS (31c), consensus (31c)
Subscribe for More Information
11:51 EDTNOVStocks with call strike movement; DAL NOV
Delta Air Lines (DAL) January 50 call option implied volatility increased 3% to 33, National Oilwell (NOV) January 50 call option implied volatility increased 2% to 31 according to IVolatility.
10:00 EDTSFLYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Altria Group (MO) downgraded to Outperform from Buy at CLSA... Baxter (BAX) downgraded to Market Perform from Outperform at Leerink... Changyou.com (CYOU) downgraded to Hold from Buy at Summit Research... Depomed (DEPO) downgraded to Neutral from Buy at Janney Capital... Euronet (EEFT) downgraded to Neutral from Buy at Monness Crespi... Foundation Medicine (FMI) downgraded to Market Perform at JMP Securities... Garmin (GRMN) downgraded to Underweight from Neutral at JPMorgan... Golden Star Resources (GSS) downgraded to Hold at Canaccord... Grainger (GWW) downgraded on negative catalysts at RBC Capital... Henry Schein (HSIC) downgraded to Hold from Buy at Evercore ISI... LINN Energy (LINE) downgraded to Market Perform from Outperform at Raymond James... LifeLock (LOCK) downgraded to Neutral from Buy at BofA/Merrill... LinnCo (LNCO) downgraded to Market Perform from Outperform at Raymond James... Manitowoc (MTW) downgraded to Hold from Buy at BB&T... PACCAR (PCAR) downgraded to Equal Weight on peak cycle concerns at Morgan Stanley... PG&E (PCG) downgraded to Neutral from Outperform at Credit Suisse... Pacer (PACR) downgraded to Equal Weight from Overweight at Morgan Stanley... Penn Virginia (PVA) downgraded to Sector Perform from Outperform at Scotia... Shutterfly (SFLY) downgraded to Market Perform at Raymond James... Terex (TEX) downgraded to Hold from Buy at BB&T... Total System (TSS) downgraded to Neutral at Baird... Whiting Petroleum (WLL) downgraded to Equal Weight from Overweight at Stephens... Whole Foods (WFM) downgraded to Equal Weight from Overweight at Morgan Stanley.
08:37 EDTSFLYShutterfly downgraded to Market Perform at Raymond James
Subscribe for More Information
07:54 EDTHPHelmerich & Payne sees FY15 CapEx $1.3B
Depreciation expense is now expected to be approximately $580M, and general and administrative expenses are now expected to be approximately $130M for fiscal 2015. Furthermore, the company expects an effective income tax rate of approximately 34% for the fourth quarter of fiscal 2015.
07:54 EDTHPHelmerich & Payne sees Q4 revenue days to decrease 3%-4% in Q4
Excluding the impact from early termination revenue during the fourth quarter of fiscal 2015, the average rig revenue per day is expected to decrease to roughly $26,000, and the corresponding average rig expense per day is expected to decrease to roughly $13,900. As of today, the U.S. land segment has approximately 156 contracted rigs that are generating revenue and 186 idle rigs. In the offshore segment, the company expects the average rig margin per day to be approximately $10,500 during the fourth fiscal quarter and revenue days to be roughly flat as compared to the third quarter of fiscal 2015. In the international land segment, the company expects revenue days during the fourth fiscal quarter to be sequentially down by 10% to 15%. Excluding the impact from early termination revenue and also as compared to the third quarter of fiscal 2015, the average rig margin per day is expected to decline by approximately 30% to 35%.
06:29 EDTSFLYShutterfly downgraded to Market Perform from Outperform at Raymond James
06:20 EDTHPHelmerich & Payne reports Q3 EPS 83c, consensus 17c
Subscribe for More Information
05:42 EDTSSHSunshine Heart provides update on C-Pulse technology
Sunshine Heart announced an update on its next generation, fully implantable version of the company's flagship C-Pulse technology. Sunshine Heart reports that it will commence a first-in-human study using the novel transcutaneous energy transmission system and a new smaller implantable pump in Q3 2016. The study will initially enroll patients at hospitals outside the U.S., and will target patients suffering from advanced Class III/IV heart failure, similar to the patient population of Sunshine Heart's current ongoing COUNTER HF Study. Feasibility of implant, safety and short term durability will be the primary objectives. Performance and efficacy data will be collected to evaluate patient quality of life, freedom from heart failure symptoms and other standard heart failure measures including the ability to bridge to other therapies. The development of a fully implantable system will eliminate the need to manage a driveline and will address the risk of exit site infections. Together with smaller and lighter wearable components, the system is designed to provide an improved quality of life for patients. The company believes this system will lead to increased market access to target all Class III HF patients, similar to CRM and neuromodulation devices. In addition, the unique ability to deliver chronic counterpulsation therapy and augment coronary blood flow, may afford a new market opportunity for the treatment of angina and ischemic heart disease where morbidity and mortality remain high in heart failure populations with reduced and preserved ejection fraction.
July 29, 2015
16:37 EDTSFLYShutterfly sees FY15 EPS (32c)-(13c), consensus (33c)
Subscribe for More Information
16:35 EDTSFLYShutterfly sees Q3 EPS ($1.47)-($1.32), consensus ($1.34)
Subscribe for More Information
16:33 EDTSFLYShutterfly reports Q2 GAAP EPS (63c),may not compare to consensus ($1.05)
Subscribe for More Information
13:19 EDTOISOil States authorizes $150M repurchase plan
Subscribe for More Information
12:53 EDTOISOil States sees Q3 well site services revenue $82M-$88M
Subscribe for More Information
12:47 EDTOISOil States sees Q3 offshore product revenue $185M-$195M
Subscribe for More Information
12:43 EDTOISOil States sees FY15 capex $150M-$160M
Subscribe for More Information
07:58 EDTEWEdwards Lifesciences price target raised to $179 from $157 at Stifel
Subscribe for More Information
07:46 EDTEWEdwards Lifesciences price target raised to $178 from $160 at Canaccord
Subscribe for More Information
07:43 EDTEWEdwards Lifesciences price target raised to $185 from $155 at Leerink
Subscribe for More Information
07:23 EDTEWEdwards Lifesciences price target raised to $168 from $155 at JPMorgan
Subscribe for More Information
07:17 EDTSFLYShutterfly volatility increases into Q2 and outlook
Shutterfly August call option implied volatility is at 43, September is at 35; compared to its 52-week range of 24 to 48, suggesting large near term price movement into the expected release of Q2 results today.
July 28, 2015
19:26 EDTOISOil States reports Q2 ex-items EPS 15c, consensus 3c
Reports Q2 revenue $269.3M, consensus $276.66M.
16:30 EDTEWEdwards Lifesciences sees Q3 EPS 92c-$1.00, consensus 98c
Sees Q3 revenue $580M-$620M, consensus $587.06M.
16:28 EDTEWEdwards Lifesciences raises FY15 EPS view to $4.30-44.40, consensus $4.28
Backs FY15 revenue view $2.3B-$2.5B, consensus $2.41B
16:26 EDTEWEdwards Lifesciences reports Q2 EPS $1.13 , consensus $1.05
Subscribe for More Information
15:21 EDTEWNotable companies reporting after market close
Subscribe for More Information
11:44 EDTPDSPrecision Drilling management to meet with Evercore ISI
Subscribe for More Information
10:52 EDTNCSNCI Building has conference call hosted by Stephens
Subscribe for More Information
07:11 EDTNOVNational Oilwell reports Q2 EPS 77c ex-items, consensus 64c
Subscribe for More Information
July 27, 2015
15:03 EDTNOVNotable companies reporting before tomorrow's open
Subscribe for More Information
10:00 EDTPTENOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:35 EDTOIIOceaneering upgraded to Buy from Accumulate at Global Hunter
Subscribe for More Information
09:33 EDTOIIOceaneering downgraded to Sector Perform from Outperform at Iberia
Subscribe for More Information
09:28 EDTPTENPatterson-UTI downgraded to Accumulate from Buy at Global Hunter
Global Hunter downgraded Patterson-UTI to Accumulate with an $18 price target. The firm downgraded shares citing an uncertain E&P spending outlook and high consensus expectations.
06:20 EDTNBRU.S. oil firms preparing for extended job cuts, WSJ reports
U.S. energy companies intend to cut more jobs, sell more assets, and engage in more financial maneuvers to deal with the recent drop in U.S. crude-oil prices to below $50 a barrel, the Wall Street Journal reports. Companies have started to warn that more layoffs will come, particularly Halliburton (HAL) and Baker Hughes (BHI), who disclosed last week that they had cut 27,000 jobs between them, the report says. Job cuts for the industry are beginning to extend to engineers and scientists, the report adds. Publicly traded companies in oil industry include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Other publicly traded companies in the space include Baker Hughes (BHI), Diamond Offshore (DO), Halliburton (HAL), Nabors Industries (NBR), Noble Corp. (NE), Rowan Companies (RDC), Schlumberger (SLB), Transocean (RIG) and Weatherford (WFT). Reference Link
July 24, 2015
10:00 EDTPDSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:30 EDTSFLYShutterfly July weekly volatility elevated into Q2 and outlook
Shutterfly August call option implied volatility is at 39, September is at 30; compared to its 52-week range of 24 to 48, suggesting large near term price movement into the expected release of Q2 results on July 29.
08:04 EDTPDSPrecision Drilling upgraded to Outperform at Scotia Howard Weil
Subscribe for More Information
06:10 EDTPDSPrecision Drilling upgraded to Outperform from Sector Perform at Scotia
Subscribe for More Information
July 23, 2015
11:57 EDTSSHSunshine Heart U.S. trial update as expected, says Piper Jaffray
Piper Jaffray said Sunshine Heart's announcements that 12 sites for its C-Pulse System study have now been reactivated and that two patients have been enrolled since resuming the trial were in line with the firm's expectations. The firm still thinks Sunshine is on track to accelerate enrollment in the next 12 months and keeps an Overweight rating and $10 price target on its shares.
10:00 EDTOIIOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:36 EDTOIIOceaneering upgraded to Hold from Underperform at Jefferies
Subscribe for More Information
06:17 EDTPDSPrecision Drilling reports Q3 EPS (10c), consensus (19c)
Subscribe for More Information
06:02 EDTPTENPatterson-UTI reports Q2 EPS (13c), consensus (27c)
Reports Q2 revenue $472.76M, consensus $439.77M.
05:39 EDTSSHSunshine Heart says 12 sites reactivated in Counter HF study for C-Pulse
Subscribe for More Information
July 22, 2015
17:08 EDTOIIOceaneering lowers FY15 EPS outlook to $2.70-$2.90 from $2.80-$3.20
FY15 EPS consensus is $2.87. Oceaneering CEO Kevin McEvoy said, "Our overall outlook for the second half of this year is down somewhat from last quarter's guidance, primarily on reduced expectations for Subsea Products and Asset Integrity. We now expect to report EPS of $1.34-$1.54 during the second half of 2015. Given this outlook and our year-to-date performance, we are lowering our 2015 EPS guidance to a range of $2.70-$2.90 from $2.80-$3.20, down about 7% at the midpoints. Relative to the first half of 2015, during the second half we expect to generate higher operating income from Subsea Products and AdTech, lower ROV and Subsea Projects results, and a similar operating income contribution from Asset Integrity... We believe our cash flow and liquidity position us well to manage our business through the current low commodity price environment. Longer-term, deepwater is still expected to continue to play a critical role in global oil supply growth required to replace depletion and meet projected demand."
17:04 EDTOIIOceaneering sees Q3 EPS 65c-75c, consensus 77c
Subscribe for More Information
17:03 EDTOIIOceaneering reports Q2 adjusted EPS 76c, consensus 68c
Subscribe for More Information
15:26 EDTPTENNotable companies reporting before tomorrow's open
Subscribe for More Information
15:26 EDTOIINotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Qualcomm (QCOM), consensus 95... American Express (AXP), consensus $1.32... Texas Instruments (TXN), consensus 65c... Las Vegas Sands (LVS), consensus 61c... Crown Castle (CCI), consensus $1.06... Discover Financial (DFS), consensus $1.32... Tractor Supply (TSCO), consensus $1.11... SanDisk (SNDK), consensus 33c... SL Green Realty (SLG), consensus $1.56... Xilinx (XLNX), consensus 54c... Weatherford (WFT), consensus (12c)... F5 Networks (FFIV), consensus $1.60... United Rentals (URI), consensus $1.74... Fortinet (FTNT), consensus 9c... LaSalle Hotel (LHO), consensus 89c... Oceaneering International (OII), consensus 68c... Cheesecake Factory (CAKE), consensus 62c.
July 21, 2015
16:25 EDTZTSZoetis files automatic mixed securities shelf
Subscribe for More Information
10:01 EDTARPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:23 EDTARPAtlas Resource Partners downgraded to Underperform at Raymond James
As previously reported, Raymond James downgraded Atlas Resource Partners to Underperform from Market Perform. The firm believes the Atlas is close to hitting leverage covenants in the wake of declining cash flows and failing commodity prices.
07:17 EDTARPAtlas Resource downgraded to Underperform from Market Perform at Raymond James
Subscribe for More Information
06:58 EDTZTSZoetis added to US 1 List at BofA/Merrill
July 20, 2015
08:38 EDTZTSAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:30 EDTZTSZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use